Gossage, L et al.[9] also found that PHD3 expression in tumor tissue indicated a worse overall disease-free survival in ampullary adenocarcinomas and pancreatic adenocarcinomas. This evidence concerns the gene EGLN3 and pancreatic adenocarcinoma.